NCT07460141 IL-6 and Hemogram-Derived Inflammatory Indices for Mortality Prediction in Postoperative ICU Patients
| NCT ID | NCT07460141 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ezgi Günaydın |
| Condition | Postoperative Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 42 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2026-03-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 42 participants in total. It began in 2025-12-15 with a primary completion date of 2026-03-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational cohort study aims to evaluate the predictive value of interleukin-6 (IL-6) levels and hemogram-derived inflammatory scores for morbidity and in-hospital mortality in postoperative patients admitted to the intensive care unit (ICU). IL-6 levels and inflammatory indices will be assessed at ICU admission and at 24 hours using data obtained from routine clinical care. Associations between these biomarkers and clinical outcomes, including mortality, morbidity, antibiotic use, and duration of mechanical ventilation, will be evaluated after adjustment for illness severity.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Postoperative patients admitted to the ICU * Availability of complete clinical and laboratory data at ICU admission and at 24 hours * Provision of informed consent by the patient or legally authorized representative Exclusion Criteria: * Age \< 18 years * Thoracic surgery patients * Cardiac surgery patients
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07460141 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Postoperative Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07460141 currently recruiting?
Yes, NCT07460141 is actively recruiting participants. Contact the research team at ezgunaydin@gmail.com for enrollment information.
Where is the NCT07460141 trial being conducted?
This trial is being conducted at Trabzon, Turkey (Türkiye).
Who is sponsoring the NCT07460141 clinical trial?
NCT07460141 is sponsored by Ezgi Günaydın. The trial plans to enroll 42 participants.